Treatment of amyotrophic lateral sclerosis using placental stem cells
US9925221B2 · kind B2 · utility
0Cited by
182References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2012 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Nov 2, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of treatment of an individual having amyotrophic lateral sclerosis, comprising administering to the individual a therapeutically effective amount of placental stem cells, e.g., tissue culture surface-adherent placental stem cells (PDACs). In one aspect, provided herein is a method of treating amyotrophic lateral sclerosis (ALS) comprising administering to an individual having ALS a therapeutically effective amount of placental stem cells. In certain embodiments, “therapeutically effective” means an amount effective to reduce or ameliorate one or more symptoms of ALS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.